Status:
TERMINATED
Personalized Warfarin Dosing by Genomics and Computational Intelligence
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Venous Thrombosis
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will create a computer program that can be used to help dose a drug called warfarin for the prevention of blood clotting. The study will collected specific information about those patients ...
Detailed Description
The objective of this project is to develop new techniques to incorporate genomic data into pharmacodynamic models to improve the dosing of chronically administered drugs. Specifically, the investigat...
Eligibility Criteria
Inclusion
- Warfarin therapy
- Attend anticoagulation clinic
- Warfarin therapy for 6 months
Exclusion
- History of non-compliance
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT00872079
Start Date
September 1 2008
End Date
September 1 2011
Last Update
February 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Medical Center, Louisville
Louisville, Kentucky, United States, 40206